These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

293 related articles for article (PubMed ID: 33515008)

  • 1. The Composition and Metabolic Potential of the Human Small Intestinal Microbiota Within the Context of Inflammatory Bowel Disease.
    Ruigrok RAAA; Collij V; Sureda P; Klaassen MAY; Bolte LA; Jansen BH; Voskuil MD; Fu J; Wijmenga C; Zhernakova A; Weersma RK; Vich Vila A
    J Crohns Colitis; 2021 Aug; 15(8):1326-1338. PubMed ID: 33515008
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Distinct effects of TU-100 (daikenchuto) on long-lasting dysbiosis in the small intestine in patients with colorectal cancer and inflammatory bowel disease.
    Kono T; Maejima T; Ono Y; Ito T; Furukawa S; Nishiyama M; Yamamoto M; Sugitani A; Karasaki H; Mizukami Y; Maemoto A
    Gene; 2022 Apr; 820():146266. PubMed ID: 35134471
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Gut microbiota differs between children with Inflammatory Bowel Disease and healthy siblings in taxonomic and functional composition: a metagenomic analysis.
    Knoll RL; Forslund K; Kultima JR; Meyer CU; Kullmer U; Sunagawa S; Bork P; Gehring S
    Am J Physiol Gastrointest Liver Physiol; 2017 Apr; 312(4):G327-G339. PubMed ID: 28039159
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Correlation of diet, microbiota and metabolite networks in inflammatory bowel disease.
    Weng YJ; Gan HY; Li X; Huang Y; Li ZC; Deng HM; Chen SZ; Zhou Y; Wang LS; Han YP; Tan YF; Song YJ; Du ZM; Liu YY; Wang Y; Qin N; Bai Y; Yang RF; Bi YJ; Zhi FC
    J Dig Dis; 2019 Sep; 20(9):447-459. PubMed ID: 31240835
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Interplay of host genetics and gut microbiota underlying the onset and clinical presentation of inflammatory bowel disease.
    Imhann F; Vich Vila A; Bonder MJ; Fu J; Gevers D; Visschedijk MC; Spekhorst LM; Alberts R; Franke L; van Dullemen HM; Ter Steege RWF; Huttenhower C; Dijkstra G; Xavier RJ; Festen EAM; Wijmenga C; Zhernakova A; Weersma RK
    Gut; 2018 Jan; 67(1):108-119. PubMed ID: 27802154
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Gut mucosal-associated microbiota better discloses inflammatory bowel disease differential patterns than faecal microbiota.
    Altomare A; Putignani L; Del Chierico F; Cocca S; Angeletti S; Ciccozzi M; Tripiciano C; Dalla Piccola B; Cicala M; Guarino MPL
    Dig Liver Dis; 2019 May; 51(5):648-656. PubMed ID: 30573380
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Microbiota of Inflammatory Bowel Disease Models.
    Gao Z; Chen KY; Mueller O; Zhang H; Rakhilin N; Chen J; Shen X
    Annu Int Conf IEEE Eng Med Biol Soc; 2018 Jul; 2018():2374-2377. PubMed ID: 30440884
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolic Functions of Gut Microbes Associate With Efficacy of Tumor Necrosis Factor Antagonists in Patients With Inflammatory Bowel Diseases.
    Aden K; Rehman A; Waschina S; Pan WH; Walker A; Lucio M; Nunez AM; Bharti R; Zimmerman J; Bethge J; Schulte B; Schulte D; Franke A; Nikolaus S; Schroeder JO; Vandeputte D; Raes J; Szymczak S; Waetzig GH; Zeuner R; Schmitt-Kopplin P; Kaleta C; Schreiber S; Rosenstiel P
    Gastroenterology; 2019 Nov; 157(5):1279-1292.e11. PubMed ID: 31326413
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Dismicrobism in inflammatory bowel disease and colorectal cancer: changes in response of colocytes.
    Tomasello G; Tralongo P; Damiani P; Sinagra E; Di Trapani B; Zeenny MN; Hussein IH; Jurjus A; Leone A
    World J Gastroenterol; 2014 Dec; 20(48):18121-30. PubMed ID: 25561781
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Deficiency of Gankyrin in the small intestine is associated with augmented colitis accompanied by altered bacterial composition of intestinal microbiota.
    Sakurai T; Nishiyama H; Nagai T; Goto S; Ogata H; Kudo M
    BMC Gastroenterol; 2020 Jan; 20(1):12. PubMed ID: 31941439
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Microbial alteration of small bowel stoma effluents and colonic feces in infants with short bowel syndrome.
    Zhang T; Wang Y; Yan W; Lu L; Tao Y; Jia J; Cai W
    J Pediatr Surg; 2020 Jul; 55(7):1366-1372. PubMed ID: 31493882
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Compositional Structure of the Small Intestinal Microbial Community via Balloon-Assisted Enteroscopy.
    Nagasue T; Hirano A; Torisu T; Umeno J; Shibata H; Moriyama T; Kawasaki K; Fujioka S; Fuyuno Y; Matsuno Y; Esaki M; Kitazono T
    Digestion; 2022; 103(4):308-318. PubMed ID: 35398852
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome.
    Vich Vila A; Imhann F; Collij V; Jankipersadsing SA; Gurry T; Mujagic Z; Kurilshikov A; Bonder MJ; Jiang X; Tigchelaar EF; Dekens J; Peters V; Voskuil MD; Visschedijk MC; van Dullemen HM; Keszthelyi D; Swertz MA; Franke L; Alberts R; Festen EAM; Dijkstra G; Masclee AAM; Hofker MH; Xavier RJ; Alm EJ; Fu J; Wijmenga C; Jonkers DMAE; Zhernakova A; Weersma RK
    Sci Transl Med; 2018 Dec; 10(472):. PubMed ID: 30567928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The dynamic distribution of porcine microbiota across different ages and gastrointestinal tract segments.
    Zhao W; Wang Y; Liu S; Huang J; Zhai Z; He C; Ding J; Wang J; Wang H; Fan W; Zhao J; Meng H
    PLoS One; 2015; 10(2):e0117441. PubMed ID: 25688558
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Faecal metabolome and its determinants in inflammatory bowel disease.
    Vich Vila A; Hu S; Andreu-Sánchez S; Collij V; Jansen BH; Augustijn HE; Bolte LA; Ruigrok RAAA; Abu-Ali G; Giallourakis C; Schneider J; Parkinson J; Al-Garawi A; Zhernakova A; Gacesa R; Fu J; Weersma RK
    Gut; 2023 Aug; 72(8):1472-1485. PubMed ID: 36958817
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Whole exome sequencing analyses reveal gene-microbiota interactions in the context of IBD.
    Hu S; Vich Vila A; Gacesa R; Collij V; Stevens C; Fu JM; Wong I; Talkowski ME; Rivas MA; Imhann F; Bolte L; van Dullemen H; Dijkstra G; Visschedijk MC; Festen EA; Xavier RJ; Fu J; Daly MJ; Wijmenga C; Zhernakova A; Kurilshikov A; Weersma RK
    Gut; 2021 Feb; 70(2):285-296. PubMed ID: 32651235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Intestinal microbiota: a source of novel biomarkers in inflammatory bowel diseases?
    Berry D; Reinisch W
    Best Pract Res Clin Gastroenterol; 2013 Feb; 27(1):47-58. PubMed ID: 23768552
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The microbiome reflects diagnosis and predicts disease severity in paediatric onset inflammatory bowel disease.
    Malham M; Lilje B; Houen G; Winther K; Andersen PS; Jakobsen C
    Scand J Gastroenterol; 2019 Aug; 54(8):969-975. PubMed ID: 31329473
    [No Abstract]   [Full Text] [Related]  

  • 19. A comparison of small bowel and fecal microbiota in children with short bowel syndrome.
    Piper HG; Coughlin LA; Nguyen V; Channabasappa N; Koh AY
    J Pediatr Surg; 2020 May; 55(5):878-882. PubMed ID: 32063370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Faecal microRNA as a biomarker of the activity and prognosis of inflammatory bowel diseases.
    Ji Y; Li X; Zhu Y; Li N; Zhang N; Niu M
    Biochem Biophys Res Commun; 2018 Sep; 503(4):2443-2450. PubMed ID: 29969632
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.